ABOUT THIS EPISODE
This episode covers three research papers relevant to postmenopausal health: a Chinese study on whether a DNA-based cervical screening test performs differently after menopause, a clarification on a vitamin D drug used for bone thinning, and a cross-sectional study on whether dental imaging can flag low bone density before a formal bone scan is ever ordered.
Key Takeaways:
• A DNA methylation test used for cervical screening (PAX1/JAM3) appears to perform differently in postmenopausal women than in premenopausal women — which matters for how results should be read and acted on.
• Eldecalcitol, a stronger vitamin D drug used in some Asian countries for postmenopausal bone thinning, is not the same as the vitamin D supplement on your shelf — the distinction matters when reading research about it.
• A type of dental X-ray called a CBCT scan can estimate bone density in the jaw, and this study found meaningful overlap with formal bone density scores (DEXA T-scores) — a possible early-detection signal that most dental visits don't flag.
• The CBCT-bone density connection is cross-sectional and preliminary — it shows an association, not a proven screening tool. Researchers are not saying "skip the DEXA."
• All three studies are observational or retrospective, conducted primarily in Asian populations, and need replication before changing clinical practice in other groups.
Sources & References:
• PAX1 and JAM3 methylation for cervical screening in pre- vs. postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42830604/) - PubMed
• Eldecalcitol and calcium supplementation for postmenopausal osteoporosis: author reply (https://pubmed.ncbi.nlm.nih.gov/42830322/) - PubMed
• Dental CT scan gray values as a predictor of bone density in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42829977/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-10-05-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
Key Takeaways:
• A DNA methylation test used for cervical screening (PAX1/JAM3) appears to perform differently in postmenopausal women than in premenopausal women — which matters for how results should be read and acted on.
• Eldecalcitol, a stronger vitamin D drug used in some Asian countries for postmenopausal bone thinning, is not the same as the vitamin D supplement on your shelf — the distinction matters when reading research about it.
• A type of dental X-ray called a CBCT scan can estimate bone density in the jaw, and this study found meaningful overlap with formal bone density scores (DEXA T-scores) — a possible early-detection signal that most dental visits don't flag.
• The CBCT-bone density connection is cross-sectional and preliminary — it shows an association, not a proven screening tool. Researchers are not saying "skip the DEXA."
• All three studies are observational or retrospective, conducted primarily in Asian populations, and need replication before changing clinical practice in other groups.
Sources & References:
• PAX1 and JAM3 methylation for cervical screening in pre- vs. postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42830604/) - PubMed
• Eldecalcitol and calcium supplementation for postmenopausal osteoporosis: author reply (https://pubmed.ncbi.nlm.nih.gov/42830322/) - PubMed
• Dental CT scan gray values as a predictor of bone density in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42829977/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-10-05-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
The American College of Physicians released a major new clinical guideline on medications for hot flashes and night sweats — and it has real implications for what treatment options your doctor will offer. This episode also covers the underreported connection between early menopause and anxiety and …
JAMA just dedicated a full special issue to menopause and chronic pain — a real signal that the research world is starting to take this seriously. This episode also covers two symptoms that often fly under the radar: dry eyes linked to estrogen decline, and changes in body odor that many women noti…
This episode covers three research stories: a Chinese retrospective study on endometrial ablation for heavy periods that won't respond to other treatment, new lab research into how the breast cancer drug fulvestrant interacts with estrogen receptors, and a large U.S. dataset connecting iron levels …
Which? analyzed the most popular menopause supplements and found they're nutritionally equivalent to a standard multivitamin that costs twenty times less. This episode also covers an 18-year study connecting the age you reach menopause to long-term brain health, and a new non-invasive test that cou…
Disclaimer: The podcast and artwork embedded on this page are from Hot Flasher, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
